Trial Information
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN‑C3 in Subjects with High
Sponsor: K-Group Beta, Inc.
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
